Reproductive pattern of parous women and the risk of cancer in later life by Pasdar, Zahra et al.
cancers
Article
Reproductive Pattern of Parous Women and The Risk of Cancer
in Later Life
Zahra Pasdar 1, Neil W. Scott 2, Lisa Iversen 3 , Philip C. Hannaford 3, Phyo Kyaw Myint 4
and Sohinee Bhattacharya 5,*


Citation: Pasdar, Z.; Scott, N.W.;
Iversen, L.; Hannaford, P.C.; Myint,
P.K.; Bhattacharya, S. Reproductive
Pattern of Parous Women and The
Risk of Cancer in Later Life. Cancers
2021, 13, 3731. https://doi.org/
10.3390/cancers13153731
Academic Editor: Matteo Lambertini
Received: 17 June 2021
Accepted: 22 July 2021
Published: 24 July 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK;
z.pasdar.17@abdn.ac.uk
2 Medical Statistics Group, Institute of Applied Health Sciences, University of Aberdeen,
Aberdeen AB25 2ZD, UK; n.w.scott@abdn.ac.uk
3 Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen,
Aberdeen AB25 2ZD, UK; l.iversen@abdn.ac.uk (L.I.); p.hannaford@abdn.ac.uk (P.C.H.)
4 Ageing Clinical & Experimental Research Team, Institute of Applied Health Sciences, University of Aberdeen,
Aberdeen AB25 2ZD, UK; phyo.myint@abdn.ac.uk
5 Aberdeen Centre for Women’s Health Research, Institute of Applied Health Sciences, University of Aberdeen,
Aberdeen AB25 2ZL, UK
* Correspondence: Sohinee.bhattacharya@abdn.ac.uk
Simple Summary: There is evidence to suggest that reproductive factors play an important role in
women’s future cancer risk, particularly hormone-dependent malignancies such as breast cancer.
However, some controversy remains regarding their effect on any cancer risk. This study aimed
to assess the risk of any cancer in a nested case-control study of fertile women living in northeast
Scotland in relation to: total number of pregnancies, cumulative time pregnant, age at first pregnancy
and interpregnancy interval. Women who were older at first delivery had an increased risk of breast
and gastrointestinal cancer, and a reduced risk of cancers of the respiratory tract and uterine cervix,
including carcinoma in situ. These findings warrant the investigation of mechanisms underpinning
these associations.
Abstract: We assessed the risk of any and site-specific cancers in a case-control study of parous
women living in northeast Scotland in relation to: total number of pregnancies, cumulative time
pregnant, age at first delivery and interpregnancy interval. We analysed 6430 women with cancer
and 6430 age-matched controls. After adjustment for confounders, women with increasing number of
pregnancies had similar odds of cancer diagnosis as women with only one pregnancy. The adjusted
odds of cancer diagnosis were no higher in women with cumulative pregnancy time 50–150 weeks
compared to those pregnant ≤ 50 weeks. Compared with women who had their first delivery at
or before 20 years of age, the adjusted odds ratio (AOR) among those aged 21–25 years was 0.81,
95% CI 0.74, 0.88; 26–30 years AOR 0.77, 95% CI 0.69, 0.86; >30 years AOR 0.63, 95% CI 0.55, 0.73.
After adjustment, the odds of having any cancer were higher in women who had an inter-pregnancy
interval >3 years compared to those with no subsequent pregnancy (AOR 1.17, 95% CI 1.05, 1.30).
Older age at first pregnancy was associated with increased risk of breast and gastrointestinal cancer,
and reduced risk of invasive cervical, carcinoma in situ of the cervix and respiratory cancer.
Keywords: pregnancy; reproductive factors; cancer
1. Introduction
Infertility in women has been linked to hormone-dependent malignancies, such as
breast and gynaecological cancer in later life [1]. While several studies have shown full
term-pregnancy to be protective, especially in relation to breast cancer [2,3], there is an
increasing body of evidence showing an association between reproductive history and the
risk of other cancers.
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Although pregnancy appears to have a protective effect on the development of breast
cancer in later life, delayed childbearing seems to negate this effect. In particular, women
who have their first child before the age of 20 have a 50% reduction in risk of breast cancer
when compared with women who have never had children [4].
Other pregnancy-related factors may play an important role with regard to breast
cancer risk in later life. A full-term pregnancy may exert different effects on the risk of
breast cancer over time—a short-term increase in risk—possibly due to increased oestrogen
production during pregnancy, followed by a long-term protection resulting from the
terminal differentiation of mammary tissue [5,6]. If this hypothesis were true, it follows
that the protective effect of pregnancy on breast cancer is exerted only when the pregnancy
is carried to term.
There is some controversy in the literature regarding the effect of a pregnancy that has
been interrupted before full term on the risk of breast cancer. While a study published in
the late 20th century observed an increased risk of breast cancer in women with a history
of spontaneous or induced abortion [7], Melbye et al. found a slight increase in the risk of
breast cancer following delivery before 32 weeks of gestation [8].
A re-analysis of data from 53 different epidemiological studies, however, came to
the conclusion that there are no harms associated with induced abortion with regard to
breast cancer risk [9]. Subsequent large-scale population-based studies also found no such
increase in risk, although the protective effect of a full-term pregnancy was not seen in
these studies either [10,11].
There is a dearth of information regarding the association between reproductive
history and other types of cancers, including endocrine cancers. Some evidence of as-
sociation exists between reproductive history and other cancers, including gastric [12],
ovarian [13,14], pancreatic [15] and renal [16] as well as overall maternal cancer mortality
and specifically breast cancer mortality [17]. However, none of these studies were able to
look at the complete reproductive history of individual women and the effect it has on
breast and other cancers.
In this study, we hypothesise that pregnancy has a protective effect on overall risk of
subsequent cancer in later life, which acts in a dose-dependent manner with an increasing
number of full-term pregnancies offering greater protection. To test the hypothesis, we
assessed the risk of any cancer in a nested case-control study of parous women living in
northeast Scotland in relation to:
a. Total number of pregnancies
b. Cumulative time pregnant
c. Age at first pregnancy
d. Interpregnancy interval
2. Materials and Methods
2.1. Ethics
Approvals to carry out the study were obtained from the Aberdeen Maternity and
Neonatal Databank (AMND) steering committee and the Privacy Advisory Committee of
the Information and Services Division (ISD) of the National Health Service (NHS) Scotland.
2.2. Sampling Frame
The AMND records and stores all pregnancy-related information about women liv-
ing in Aberdeen city and district from 1950 onwards. It now has information on over
250,000 pregnancies occurring in these women. Complete reproductive histories of indi-
vidual women can be constructed using internal data linkage [18]. Records, including
identifiers, of individual women who were born before 1968 (i.e., those older than 40 at the
time of the data linkage for this study, the age when the incidence of most types of cancer
increases substantially) and who had at least their first full-term pregnancy recorded on the
AMND were supplied to the ISD of NHS Scotland. Information on baseline characteristics,
including age, social class, smoking habits, height and marital status at the time of the
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first pregnancy, was extracted from the AMND at the time of the identification of these
women. Exposure variables of the total number of pregnancies, plus date and outcome of
each pregnancy (live birth, miscarriage, ectopic pregnancy, induced abortion or stillbirth)
were extracted as well.
The ISD collect and collate information about all hospital admissions, as well as cancer,
birth and death registrations, in Scotland in the Scottish Morbidity Records (SMR). The
cohort of women identified from the AMND were linked by ISD in 2008 to the national
Cancer Registry (SMR06) and to death notifications supplied by the General Register Office
(GRO-S) using probability matching. This linkage process involves using identifiers such as
name, date of birth and post code to find the closest match. After the linkage, all identifiers
were removed by ISD and we were supplied with a pseudo-anonymised (but containing
the AMND unit number) and linked study database. All women who were linked to
the Scottish registers were then traced on the Community Health Index (CHI) register in
Scotland by the Data Management Team, University of Aberdeen (who have access to both
registers) to make sure that all linked women had their complete reproductive histories
recorded in the AMND. Any woman who had moved out of Aberdeen before the age of
55 years was excluded from the analysis. Figure 1 shows the process of identifying cases
and controls.
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Figure 1. Flow chart of selection of cases (women with cancer) and controls (women without cancer). 
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n = 6430 
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(n = 7327) 
Untraced on CHI 
(n = 206) 
Figure 1. Flow chart of selection of cases (women with cancer) and controls (women without cancer).
2.3. Study Design
Using the linked dataset as the sampling frame, we conducted a nested case-control
study. Cases were all women in the linked dataset with a cancer diagnosis (identified from
SMR06) and/or recorded death from cancer (identified from GRO-S). For each case, we
Cancers 2021, 13, 3731 4 of 13
randomly identified one control born within two years of the case’s year of birth. Controls
did not have a history of cancer at the time of the case’s diagnosis. We excluded cases who
had cancer prior to their first pregnancy or during pregnancy. Moreover, women who left
Aberdeen before they were likely to have completed their families were also excluded after
tracing on the CHI register. This was because we could not be certain of the completeness
of their reproductive histories. After applying all the exclusions, there were 6430 cases of
cancer and 6430 controls available for statistical analysis.
2.4. Definition of Variables
A case was defined as having a record in the Scottish Cancer Registry (SMR06) and/or
having a record of death associated with cancer. The site of cancer is coded according to
ICD-9 or -10 classifications in this registry and these are presented in the supplementary
Table S1 with the broad categories used in this analysis. The exposure variables, such as
total number of pregnancies and age at first delivery, were all extracted from the AMND
directly. The cumulative time pregnant was calculated by adding together the gestational
age at the end of each pregnancy. Interpregnancy interval was calculated by subtracting
the date of the second delivery from that of the first one and also subtracting the duration
of gestation of the subsequent pregnancy. Potential confounders available from the AMND
included the Registrar General’s occupation-based social class (non-manual: classes 1, 2
and 3a and manual: classes 3b to 7) and self-reported smoking habit at the time of the
first pregnancy. Height, weight and marital status at the time of first pregnancy were also
recorded at the time of the first antenatal visit. As weight was poorly recorded for a large
proportion of women or recorded at an advanced gestational age, we adjusted for height,
which has been shown to be associated with cancer [19].
2.5. Statistical Analysis
Personal (social class, smoking habits, height, weight and marital status at time of
first pregnancy) and reproductive characteristics consisted of total number of pregnancies,
number of pregnancies of normal duration, cumulative time pregnant (in weeks), age
at first delivery and inter-pregnancy interval, which were compared between cases and
controls using appropriate descriptive statistics. We included in the multivariable analyses
variables that were potential confounders and did not have a high proportion of missing
data (see below). The non-manual social class formed the reference group for analysis.
Similarly, current and ex-smokers were classified together as having ever smoked, with the
“never smoked” group as the reference category. Conditional logistic regression was used
to calculate the odds ratio and corresponding 95% confidence interval for the development
of any cancer among women with different reproductive characteristics, adjusted for height
and age at first delivery (except where age at first delivery was being examined). Subgroup
analyses were then conducted according to the site of cancer (breast, uterus, invasive
uterine cervix, ovary, carcinoma in situ of cervix, skin, respiratory, gastro-intestinal and all
other cancers).
2.6. Missing Data
There was a substantial proportion of missing data (from one-third to one-half) in the
variables weight, social class and smoking status. A large number of women, mostly those
who had their first deliveries in the 1950s, had missing data for smoking. As smoking is
likely to be an important confounder for some cancers, an additional subgroup analysis
by smoking status was conducted including only those women with known smoking
history. For clarity of presentation, only the adjusted odds ratios (AORs) are presented
for this subgroup analysis. For the other potential confounders, BMI and social class, the
proportion of missing data was too high to consider multiple imputation. We did not
conduct any further subgroup analyses for these missing data because where data were
complete, as they did not appear to vary by case-control status.
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3. Results
3.1. Baseline Characteristics:
Women with cancer were younger at the time of their first delivery than controls
(23.9 versus 24.5 years, respectively), and more likely to be current or ex-smokers at the
time of their first pregnancy (60.3% versus 44.3%; Table 1).





(Max n = 6430)
Controls
(Max n = 6430]
Mean (SD) [n] Mean (SD) [n]
Age at first delivery 23.9 (4.9) [n = 6420] 24.5 (5.0) [n = 6422]
Height (cm) 159.8 (6.0) [n = 6385] 159.5 (6.1) [n = 6384]
BMI 23.3 (3.3) [n = 2135] 23.7 (3.6) [n =2 309]
n (% of known) n (% of known)
Social class Manual 3442 (68.9%) 3611 (69.8%)
Non-Manual 1553 (31.1%) 1559 (30.2%)
Not known 1435 1260
Ever smoked? No 1029 (39.7%) 1435 (55.7%)
Yes 1564 (60.3%) 1142 (44.3%)
Not known 2577 2593
Marital status Single 686 (10.7%) 474 (7.4%)
Married/cohabiting 5703 (88.7%) 5908 (91.9%)
Divorced/separated 40 (0.6%) 46 (0.7%)
Not known 1 2
3.2. Reproductive Patterns
Following their first delivery, there were 4798 live births, 84 stillbirths, 646 miscar-
riages, 687 terminations and 49 ectopic pregnancies in the group of women who subse-
quently developed cancer. Among controls (women not diagnosed with cancer), there were
4660 live births, 78 stillbirths, 687 miscarriages, 689 terminations and 45 ectopic pregnancies
following the first delivery.
Table 2 presents the reproductive patterns by case-control status. After adjusting for
height and age at first delivery, there was no clear evidence that women with increasing
number of pregnancies had higher odds of cancer diagnosis compared with those who
had only one pregnancy—AOR 1.03 (95% CI 0.95, 1.13), 1.03 (0.93, 1.15), 1.10 (0.94, 1.28)
and 1.10 (0.89, 1.35) for 2, 3, 4 and 5+ pregnancies, respectively. When only pregnancies of
normal duration (>37 weeks gestation) were considered, the adjusted odds of cancer in
women with two or more pregnancies were not statistically significantly different than in
those who had only one pregnancy of normal duration although the unadjusted odds ratios
showed an increased odds in women with 2 or more pregnancies. In terms of cumulative
time pregnant, the adjusted odds of cancer diagnosis were no different in women who had
been pregnant for 50–150 weeks compared to those who had been pregnant for 50 weeks or
less in their reproductive life—AOR (95% CI) of 1.07 (0.97, 1.18), 1.08 (0.96, 1.22) and 1.17
(1.00, 1.38) for 51–100, 100–150 and more than 151 weeks, respectively. Once again, on the
unadjusted analysis, cumulative time pregnant for more than 50 weeks was significantly
associated with a cancer diagnosis.
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Table 2. Comparison of reproductive variables between women with (cases) and without (controls) cancer.
Total Number of
Pregnancies
Cases (n = 6429)
n (%)






1 (reference) 1620 (25.2%) 1763 (27.4%) 1 1
2 2758 (42.9%) 2775 (43.2%) 1.08 (0.99, 1.18) 1.03 (0.95, 1.13)
3 1320 (20.5%) 1258 (19.6%) 1.14 (1.03, 1.26) 1.03 (0.93, 1.15)
4 489 (7.6%) 429 (6.7%) 1.24 (1.07, 1.44) 1.10 (0.94, 1.28)
5+ 242 (3.8%) 204 (3.2%) 1.30 (1.06, 1.58) 1.10 (0.89, 1.35)
Not known 1 1
No. of pregnancies of
normal duration
Cases (n = 6429)
n (%)






1 (reference) 1416 (22.0%) 1589 (24.7%) 1 1
2 2451 (38.1%) 2397 (37.3%) 1.15 (1.05, 1.26) 1.10 (1.00, 1.21)
3 1356 (21.1%) 1353 (21.0%) 1.13 (1.02, 1.26) 1.03 (0.92, 1.15)
4 687 (10.7%) 621 (9.7%) 1.25 (1.10, 1.43) 1.11 (0.96, 1.27)
5+ 519 (8.1%) 469 (7.3%) 1.25 (1.08, 1.45) 1.07 (0.92, 1.25)
Not known 1 1
Cumulative time
pregnant (weeks)
Cases [n = 5718]
n (%)






≤50 1469 (25.7%) 1639 (28.5%) 1 1
51–100 2568 (44.9%) 2590 (45.0%) 1.11 (1.01, 1.22) 1.07 (0.97, 1.18)
100–150 1169 (20.4%) 1096 (19.0%) 1.19 (1.06, 1.33) 1.08 (0.96, 1.22)
151+ 512 (9.0%) 432 (7.5%) 1.34 (1.15, 1.57) 1.17 (1.00, 1.38)
Not known 712 673
Age at first delivery Cases [n = 6419]n (%)






≤20 1705 (26.6%) 1439 (22.4%) 1 1
21–25 2656 (41.4%) 2731 (42.5%) 0.81 (0.74, 0.89) 0.81 (0.74, 0.88)
26–30 1417 (22.1%) 1477 (23.0%) 0.79 (0.71, 0.88) 0.77 (0.69, 0.86)
31+ 641 (10.0%) 774 (12.1%) 0.65 (0.57, 0.75) 0.63 (0.55, 0.73)
Not known 11 9
Interpregnancy interval Cases (n = 5895)n (%)







pregnancy 1662 (28.2%) 1823 (30.9%) 1 1
<3 years 2606 (44.2%) 2611 (44.2%) 1.11 (1.02, 1.22) 1.05 (0.96, 1.16)
≥3 years 1627 (27.6%) 1470 (24.9%) 1.23 (1.12, 1.37) 1.17 (1.05, 1.30)
Not known 535 526
* Conditional logistic regression. ** Conditional logistic regression adjusted for height and age at first delivery. *** Conditional logistic
regression adjusted for height. Statistically significant odds ratios are shown as bold.
The inverse relationship between cancer and age at first delivery persisted following
adjustment for maternal height. Compared with women who had their first delivery at
or before the age of 20 years, the AOR among those who were aged 21–25 years was
0.81, 95% CI 0.74, 0.88; 26–30 years, AOR 0.77, 95% CI 0.69, 0.86; >30 years, AOR 0.63,
95% CI 0.55, 0.73. After adjusting for height and age at first delivery, the odds of having
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any cancer remained higher in women who had an inter-pregnancy interval greater than
3 years compared with those with no subsequent pregnancy (AOR 1.17, 95% CI 1.05, 1.30).
Tables 3 and 4 present the subgroup analyses by cancer site. The descriptive statis-
tics for subgroup analyses by cancer site is detailed in Tables S2 and S3 of the online
supplementary files, respectively. Increased adjusted odds ratios for breast cancer were
observed in women who were pregnant for longer periods, as reflected in the total number
of pregnancies, cumulative time pregnant and shorter inter-pregnancy intervals (Table 3).
Having two pregnancies as opposed to one was associated with an increased risk of breast
cancer (AOR 1.25, 95% CI 1.01, 1.56); as was three or more pregnancies of normal duration
(AOR 1.27, 95% CI 1.01, 1.60). There appeared to be a dose response relationship between
the cumulative time a woman was pregnant and breast cancer with an AOR of 1.26 (95%
CI 1.01, 1.58) and 1.43 (95% CI 1.10, 1.86) of developing breast cancer if cumulative time
pregnant was 51 to 100 weeks or more than 100 weeks, respectively. After adjusting for
height, there appeared to be an association between older age at first delivery and breast
cancer diagnosis. The odds of having breast cancer were increased in women who had their
first delivery after the age of 20 years, although this only reached statistical significance in
the age group 26 to 30 years (AOR 1.44, 95% CI 1.11, 1.86). Women with an interpregnancy
interval of less than 3 years between pregnancies had statistically significantly higher odds
of developing breast cancer (AOR 1.40, 95% CI 1.12, 1.74) than women with no subsequent
pregnancies. Age at first delivery of less than 20 years was associated with both invasive
cancer of the uterine cervix and carcinoma in situ.
Table 3. Subgroup analyses by cancer site (breast/gynaecological cancers): reproductive variables by case-control status.
Reproductive
Pattern Breast Uterus Uterine Cervix Ovary Carcinoma In Situ
Adj OR Adj OR Adj OR Adj OR Adj OR
Total number of
pregnancies n = 2386 n = 228 n = 296 n = 202 n = 3080
1 (reference) 1 1 1 1 1
2 1.25 (1.01, 1.56) 0.89 (0.46, 1.70) 1.12 (0.61, 2.04) 1.82 (0.83, 3.98) 0.91 (0.74, 1.13)
3+ 1.21 (0.96, 1.52) 0.96 (0.46, 2.00) 0.95 (0.50, 1.80) 0.66 (0.31, 1.44) 1.01 (0.81, 1.26)
No. of pregnancies
of normal duration n = 2386 n = 228 n = 296 n = 202 n = 3080
1 (reference) 1 1 1 1 1
2 1.16 (0.95, 1.42) 0.86 (0.45, 1.64) 1.04 (0.60, 1.81) 1.68 (0.81, 3.52) 0.81 (0.67, 0.98)
3+ 1.27 (1.01, 1.60) 0.91 (0.47, 1.78) 1.37 (0.73, 2.56) 0.62 (0.27, 1.43) 0.85 (0.69, 1.05)
Cumulative time
pregnant (weeks) n = 1900 n = 186 n = 222 n = 156 n = 2532
≤50 1 1 1 1 1
51–100 1.26 (1.01, 1.58) 0.91 (0.47, 1.78) 1.01 (0.54, 1.88) 1.16 (0.50, 2.68) 0.90 (0.73, 1.11)
101+ 1.43 (1.10, 1.86) 0.90 (0.38, 2.14) 1.36 (0.64, 2.86) 0.46 (0.17, 1.24) 0.92 (0.72, 1.17)
Age at first
delivery * n = 2386 n = 228 n = 296 n = 202 n = 3080
≤20 1 1 1 1 1
21–25 1.24 (1.00, 1.55) 1.19 (0.62, 2.29) 0.23 (0.12, 0.46) 1.36 (0.58, 3.18) 0.64 (0.54, 0.76)
26–30 1.44 (1.11, 1.86) 2.15 (0.91, 5.11) 0.37 (0.16, 0.86) 1.12 (0.48, 2.61) 0.39 (0.32, 0.49)
Cancers 2021, 13, 3731 8 of 13
Table 3. Cont.
Reproductive
Pattern Breast Uterus Uterine Cervix Ovary Carcinoma In Situ
Adj OR Adj OR Adj OR Adj OR Adj OR
31+ 1.36 (0.97, 1.90) 0.69 (0.18, 2.70) 0.12 (0.03, 1.05) 0.52 (0.15, 1.79) 0.22 (0.16, 0.31)
Interpregnancy
interval n = 2038 n = 204 n = 246 n = 172 n = 2394
No subsequent
pregnancy 1 1 1 1 1
<3 years 1.40 (1.12, 1.74) 0.77 (0.39, 1.51) 1.27 (0.71, 2.27) 1.14 (0.52, 2.54) 0.85 (0.69, 1.05)
>3 years 1.22 (0.95, 1.57) 1.11 (0.51, 2.45) 1.60 (0.82, 3.15) 1.42 (0.61, 3.31) 0.94 (0.74, 1.19)
Conditional logistic regression adjusted for height and age at first delivery. * Conditional logistic regression adjusted for height. N (Ca):
number of cases, N (Co): number of controls (NB: not all are included in the conditional logistic regression because of missing data in
covariates). Statistically significant odds ratios shown in bold.
Table 4. Subgroup analyses by cancer site (non-gynaecological cancers): reproductive variables by case-control status.
Reproductive
Pattern Skin Respiratory Gastrointestinal Other Cancers
Adj OR Adj OR Adj OR Adj OR
No of pregnancies of
normal duration n = 684 n = 942 n = 1312 n = 3146
1 (reference) 1 1 1 1
2 0.92 (0.60, 1.43) 1.35 (0.95, 1.92) 1.35 (1.01, 1.79) 1.21 (1.00, 1.46)
3+ 0.89 (0.57, 1.37) 1.27 (0.88, 1.84) 1.21 (0.90, 1.63) 1.00 (0.82, 1.22)
Total no. of pregnancies n = 684 n = 942 n = 1312 n = 3146
1 (reference) 1 1 1 1
2 1.09 (0.72, 1.65) 1.29 (0.93, 1.80) 1.37 (1.04, 1.81) 1.14 (0.95, 1.36)
3+ 0.99 (0.64, 1.53) 1.33 (0.92, 1.92) 1.28 (0.95, 1.72) 1.05 (0.86, 1.28)
Cumulative time
pregnant (weeks) n = 574 n = 692 n = 1070 n = 2498
≤50 1 1 1 1
51–100 0.89 (0.57, 1.40) 1.19 (0.82, 1.73) 1.50 (1.11, 2.03) 1.17 (0.96, 1.43)
101+ 0.90 (0.55, 1.45) 1.29 (0.84, 1.97) 1.27 (0.91, 1.78) 1.15 (0.91, 1.44)
Age at first delivery * n = 684 n = 942 n = 1312 n = 3146
≤20 1 1 1 1
21–25 0.99 (0.66, 1.48) 0.70 (0.49, 1.00) 1.22 (0.88, 1.70) 0.83 (0.69, 1.00)
26–30 0.80 (0.50, 1.26) 0.61 (0.40, 0.93) 1.43 (0.97, 2.09) 0.99 (0.79, 1.25)
31+ 0.64 (0.35, 1.16) 0.54 (0.31, 0.95) 1.73 (1.08, 2.76) 0.94 (0.71, 1.26)
Interpregnancy interval n = 584 n = 808 n = 1190 n = 2736
No subsequent
pregnancy 1 1 1 1
<3 years 0.87 (0.57, 1.33) 1.09 (0.77, 1.55) 1.27 (0.96, 1.68) 1.08 (0.89, 1.30)
>3 years 0.81 (0.50, 1.30) 1.35 (0.93, 1.95) 1.31 (0.97, 1.78) 1.33 (1.08, 1.63)
Conditional logistic regression adjusted for height and age at first delivery. * Conditional logistic regression adjusted for height. N (Ca):
number of cases, N (Co): number of controls (NB: not all are included in the conditional logistic regression because of missing data in
covariates). Statistically significant odds ratios are shown in bold.
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Of the non-gynaecological sites examined (Table 4), only cancer of the gastrointestinal
tract was statistically significantly associated with reproductive variables. Similar to breast
cancer, the adjusted odds ratios of gastrointestinal cancer were increased in women who
had two pregnancies (regardless of duration) compared to one. Women who were pregnant
for 51 to 100 weeks during their reproductive life had a higher chance of developing
gastrointestinal cancer compared to those who were pregnant for 50 weeks or less (AOR
1.50, 95% CI 1.11, 2.03). Compared to those who were aged 20 or younger at the time of their
first delivery, women who delivered when they were over the age of 31 had a significantly
higher risk of developing gastrointestinal cancer in later life. None of the other site-
specific cancers showed any clear evidence of associations with the reproductive variables
examined apart from interpregnancy interval of greater than 3 years was associated with
an increased risk of other cancers.
Table 5 presents the main analysis for any cancer diagnosis, stratified by women
whose smoking habits were recorded at the time of their first delivery. Non-smokers who
had four pregnancies of normal duration as opposed to one, those who were pregnant for
151 weeks or more during their reproductive life or those who were older than 26 years at
the time of their first delivery had significantly lower odds of developing any cancer in
later life after adjustment for height and age at delivery. In current or past smokers, age at
delivery when younger than 20 years was associated with an increased risk of cancer.
Table 5. Subgroup analyses including only those with known smoking status: reproductive variables by case-control status.
Reproductive
Pattern Non-Smoker Current/Past Smoker
N (Ca) N (Co) Adj OR N (Ca) N (Co) Adj OR
No. of pregnancies of
normal duration n = 2439 n = 2664
1 (reference) 379 252 1 252 309 1
2 581 427 1.00 (0.81, 1.23) 478 614 0.94 (0.76, 1.16)
3 302 212 0.88 (0.69, 1.13) 248 357 0.99 (0.78, 1.27)
4 117 91 0.92 (0.66, 1.28) 100 159 1.03 (0.75, 1.42)
5+ 56 47 0.93 (0.60, 1.44) 64 125 1.19 (0.82, 1.72)
Total 1435 1029 1142 1564
Total number of
pregnancies n = 2439 n = 2664
1 (reference) 416 282 1 301 395 1
N (Ca) N (Co) Adj OR N (Ca) N (Co) Adj OR
2 695 489 0.92 (0.75, 1.12) 559 730 0.88 (0.73, 1.07)
3 243 212 1.03 (0.80, 1.33) 206 296 0.91 (0.71, 1.16)
4 64 37 0.63 (0.40, 0.99) 59 107 1.07 (0.74, 1.55)
5+ 17 9 0.55 (0.24, 1.27) 17 36 1.19 (0.65, 2.18)
Total 1435 1029 1142 1564
Cumulative time
pregnant (weeks) n = 2251 n = 2390
≤50 389 260 1 268 336 1
51–100 664 458 0.93 (0.76, 1.15) 523 676 0.92 (0.75, 1.13)
100–150 225 179 0.99 (0.76, 1.29) 188 277 0.97 (0.74, 1.26)
151+ 62 33 0.62 (0.39, 0.98) 53 105 1.22 (0.83, 1.79)
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Table 5. Cont.
Reproductive
Pattern Non-Smoker Current/Past Smoker
Total 1340 930 1032 1394
Age at first delivery * n = 2439 n = 2664
≤ 20 256 240 1 354 628 1
21–25 486 378 0.83 (0.66, 1.03) 446 565 0.72 (0.60, 0.86)
26–30 398 269 0.70 (0.55, 0.90) 220 265 0.67 (0.53, 0.84)
31+ 292 139 0.50 (0.38, 0.65) 121 106 0.48 (0.35, 0.64)
Total 1432 1026 1141 1564
Interpregnancy
interval n = 2204 n = 2355
No subsequent
pregnancy 425 290 1 296 373 1
<3 years 573 419 0.96 (0.79, 1.18) 434 592 0.94 (0.77, 1.16)
>3 years 294 220 0.97 (0.77, 1.23) 277 415 1.02 (0.82, 1.28)
Total 1292 929 1007 1380
Logistic regression adjusted for height and age at first delivery; * Logistic regression adjusted for height; N (Ca): number of cases, N (Co):
number of controls.
4. Discussion
To the best of our knowledge, this is the first study which explored several pregnancy-
related factors and their association with any cancer in parous women. Our results showed
that the odds of developing any cancer were statistically significantly reduced with in-
creasing age at first delivery. Cancer diagnosis was also associated with inter-pregnancy
intervals longer than 3 years. However, breast cancer risk was increased in women with
delayed childbearing and with longer time pregnant, as reflected by higher cumulative time
pregnant and shorter interpregnancy intervals. Older age at first delivery was associated
with a reduced risk of invasive cancer of the uterine cervix, carcinoma in situ and cancers
of the respiratory tract.
Although there have been several reports of associations between infertility and
hormone-dependent cancer [1,20,21], there is controversy regarding the effect of repro-
ductive patterns in parous women on subsequent cancer risk. It was shown as early as
1926 by Lane-Claypon [22] that increasing parity was a protective factor for breast cancer.
Later, MacMahon et al. conducted a multicentre case-control study in seven countries all
over the world and found that younger maternal age at first term birth, rather than total
parity, protected against breast cancer [23]. Several subsequent studies have confirmed
these findings [2,24–26]. We found slightly different results. Whilst we also found that
breast cancer risk was increased in women who had their first delivery after age 20 years,
in a subgroup analysis, being pregnant for longer increased the chances of breast cancer.
There could be several explanations for this different pattern of risk. First, the reference
category in our study for maternal age at first delivery analysis was less than 20 years, and
it is possible that the protective effect of earlier age at first delivery disappeared even earlier
than previously thought. The positive association seen with cumulative time pregnant may
be explained by the longer duration the breast is subjected to pregnancy hormones. This
hypothesis is consistent with the excess risk of breast cancer observed in oral contraceptive
users [27]. The protective effect of high parity observed by others may be explained by the
duration of breast feeding [28].
Although the reduction of risk seen with cumulative time pregnant (>101 weeks) on
cancer of the uterus was not statistically significant in this study, a recent analysis found
that whilst there is a greater magnitude of reduction in risk for a full-term pregnancy than
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an early pregnancy loss, each additional pregnancy is associated with a further reduction
in endometrial cancer risk [29].
The similar reproductive pattern seen in our subgroup analysis of women with gas-
trointestinal cancer has not been described before, although a Swedish national record
linkage study involving 406,439 women did not find a protective effect of increasing parity
on the development of stomach cancer [12].
The main strength of this study lies in the quality of the data recorded in the databases
(AMND and the Scottish Registers) used for record linkage. These databases are almost
100% complete in terms of case ascertainment and have been in existence since the 1950s,
thereby reducing the possibility of selection bias. Many other studies have utilised women’s
recall of reproductive events, which may be subject to recall bias. We are confident in the
completeness of our records of reproductive history, as they are recorded contemporane-
ously at the time of pregnancy. Moreover, we excluded all women who could not be traced
on the CHI register before they were likely to have completed their families. Cases and
controls were matched on year of birth. This controlled for an important confounder, as
cancer risk varies by age and over time.
An obvious limitation of this study is that we only looked at women who had at least
one full-term pregnancy, thereby missing any “all or none” protective effect of pregnancy
and term delivery on subsequent development of cancer. Another weakness of this study
was the inability to adjust for potential confounding factors, notably breast feeding, BMI,
exogenous hormone use and smoking. The AMND contains information about breast
feeding at discharge from hospital. We did not adjust for this variable in our analyses for
two reasons—first, data were missing in a substantial proportion of pregnancies; second,
even where they were available, feeding status at discharge from hospital does not capture
the duration of breast feeding, which is of more relevance to breast cancer risk. We were
able to do a subgroup analysis where smoking data were available, which achieved similar
results overall. The women were identified from the AMND, and although they are
representative of the local population, the observed findings may not be generalisable to a
wider population. Moreover, we had relatively few women with higher-order parity in
our dataset, so our study could have been underpowered to observe the protective effect
seen in previous reports. Another limitation is multiple statistical testing and significant
findings due to chance alone.
Interestingly, breast cancer risk showed a different direction of effect of reproductive
factors, such as interpregnancy interval to other cancers risk. As the other cancer categories
contained a mixed bag of different cancers, as shown in the supplementary table, with
no specific site predominating, it would be presumptuous of us to draw any conclusions
from this. This may possibly be a chance finding as numbers of any particular subtype
categorised as “others” was low.
Despite the limitations, this study shows that reproductive patterns in parous women
could be used to identify women at risk of developing cancer in later life. Together
with genetic and environmental risk factors, such as smoking, reproductive patterns may
be included in prediction models to assess the risk of cancer in women at an early age.
Preventing teenage pregnancies would have the added benefit of reducing the risk of
cancer. Future research needs to focus on the mechanistic explanations of the associations
found in this and other epidemiological studies. For example, this cohort predated the
rollout of HPV immunisations in Scotland. The association shown in this study between
younger age at first delivery with cervical cancer may be explained by increased rates of
HPV infection in women who were sexually active at a younger age.
5. Conclusions
For women who had been pregnant at least once, there was evidence of a small
increase in the risk of any cancer among those having subsequent pregnancies. Older age at
first pregnancy was associated with increased risk of breast and gastrointestinal cancer and
a reduced risk of invasive cervical, carcinoma in situ of the cervix and respiratory cancer.
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